{
	"kj8tvrn6Text": "Brinte<span class=\"_ _1\"></span>llix® improv<span class=\"_ _0\"></span>es<span class=\"_ _1\"></span> ev<span class=\"_ _0\"></span>er<span class=\"_ _1\"></span>yday func<span class=\"_ _b\"></span>tioning<span class=\"_ _1\"></span> as <br><span class=\"ls0 wsa\">repo<span class=\"_ _0\"></span>r<span class=\"_ _1\"></span>ted b<span class=\"_ _2\"></span>y the pa<span class=\"_ _0\"></span>tien<span class=\"_ _0\"></span>t*<span class=\"fs2 lsf ws1b v1\">1,<span class=\"_ _1\"></span>2</span></span>",
	"kj8tvrn7Text": "Short term<span class=\"_ _e\"> </span><span class=\"ff3 fc0\">Long term</span>",
	"kj8tvrn8Text": "Florea ",
	"kj8tvrn9Text": "Meta analysis",
	"kj8tvrnaText": "*As measured by SDS; **5 mg and 15 mg doses were not shown to be sta<span class=\"_ _0\"></span>tistically significant.<span class=\"fsd ls0 ws1c v2\">†</span> 5 mg dose is only recommended starting dose in elderly.<span class=\"fsd ls0 v2\">2<br></span><span class=\"v2\">F<span class=\"_ _2\"></span>AS, full-analysis set; SDS, Sheehan disability scale.</span>",
	"kj8tvrnbText": "Brintellix® 10 mg and 20 mg** significantly improved over<span class=\"_ _0\"></span>all patient <br>functioning at work,<span class=\"_ _0\"></span>  <span class=\"_ _f\"></span>at home and socially compared with placebo a<span class=\"_ _0\"></span>t <br>eight weeks, as measur<span class=\"_ _0\"></span>ed by SDS<span class=\"fsf v3\">†</span>",
	"kj8tvrncText": "WORK / S<span class=\"_ _0\"></span>TUDIES<span class=\"_ _10\"> </span>SOCIAL LIFE /  <span class=\"_ _11\"></span>LEISURE ",
	"kj8tvrndText": "ACTIVITIES",
	"kj8tvrneText": "HOME LIFE / HOME ",
	"kj8tvrnfText": "RESPONSIBILITIES",
	"Brintellix_31c7448153": "Lorem ipsum dolor sit amet",
	"Brintellix_316a0fe758": "Tab 3 -- Consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.",
	"Brintellix_31dd06d6b9": "Lorem ipsum dolor sit amet",
	"Brintellix_31bc710392": "Consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.",
	"Brintellix_31cdb568f1": "<span style=\"font-family: &quot;1_CWOXIJ+AvenirNextLTPro-Bold&quot;; color: rgb(232, 87, 0); line-height: 3;\"><div style=\"text-align: center;\"><span style=\"font-size: 22.5px;\">Short term</span></div>\n</span>",
	"Brintellix_31152951e6": "<span style=\"font-family: &quot;3_CCMVBT+AvenirNextLTPro-Demi&quot;; color: rgb(84, 122, 129); text-align:center;\">\n<font style=\"font-size: 22.5px;line-height: 3;display: block;text-align: center;\">Long term</font>\n</span>",
	"Brintellix_31d5533218": "<span style=\"font-family: &quot;1_CWOXIJ+AvenirNextLTPro-Bold&quot;; line-height: 1; color: rgb(100, 94, 94); display: block;\">\n<font style=\"font-size: 17px;\">\nThe effect of Brintellix<sup>®</sup> on everyday functioning observed in three short-term <br>\nstudies was sustained and further improved for up to 12 months as assessed&nbsp;</font></span><span style=\"font-family: &quot;1_CWOXIJ+AvenirNextLTPro-Bold&quot;; line-height: 1; color: rgb(100, 94, 94); display: block;\"><font style=\"font-size: 17px;\">by SDS<sup>**2</sup>\n</font>\n</span>",
	"Brintellix_31e1019ac7": "<span style=\"font-family: &quot;1_CWOXIJ+AvenirNextLTPro-Bold&quot;; color: #e85700; \">\n<font style=\"font-size: 15px;\">Study Design</font>\n</span>",
	"Brintellix_31bf5f5c0e": "<p style=\"font-family: &quot;2_PIDSIJ+AvenirNextLTPro-Regular&quot;; color: rgb(100, 94, 94); line-height: 1;display:block;\">\n<font style=\"font-size: 11.5px;\">\n\t*As measured by SDS.\n\t<span style=\"display: inline-block;padding-top: 10px;\">**At 15 mg and 20 mg doses once-daily.</span>\n\t<span style=\"display: inline-block;padding-top: 10px;\">This was a 52-week, flexible-dose, open-label extension study in patients who completed one of three randomised, <br>\n\tdouble-blind, placebo-controlled, eight-week Brintellix<sup>®</sup> trials. All patients were switched to 10 mg/day Brintellix<sup>®</sup> for <br>\n\tWeek 1, then adjusted between 15 mg and 20 mg for the remainder of the study, but not down-titrated below 15 mg. <br>\n\tOf the 1075 patients enrolled, 1073 received at least one dose of Brintellix<sup>®</sup> and 538 (50.0%) completed the study. </span><br>\n\t<span style=\"display: inline-block;padding-top: 10px;\">FAS, full-analysis set; SDS, Sheehan disability scale.</span>\n</font>\n</p>",
	"Brintellix_31b134b69d": "<span style=\"font-family: &quot;1_CWOXIJ+AvenirNextLTPro-Bold&quot;; color: rgb(84, 122, 129); \">\n<font style=\"font-size: 17.5px;\">Mean SDS total scores in adult patients with MDD<sup>2</sup></font>\n</span>",
	"Brintellix_3142145310": "<span style=\"font-family: &quot;1_CWOXIJ+AvenirNextLTPro-Bold&quot;; color: rgb(84, 122, 129); \">\n<font style=\"font-size: 15px;\">Weeks in study</font>\n</span>",
	"Brintellix_311b879e7f": "<p style=\"font-family: &quot;2_PIDSIJ+AvenirNextLTPro-Regular&quot;; color: rgb(100, 94, 94); line-height: 1;display:block;\">\n<font style=\"font-size: 11.5px;\">\n\t*As measured by SDS.<br>\n\t<span style=\"display: inline-block;padding-top: 10px;\">**At 15 mg and 20 mg doses once-daily.</span>\n\t<span style=\"display: inline-block;padding-top: 10px;line-height:1.3;\">This was a 52-week, flexible-dose, open-label extension study in patients who completed one of three randomised, <br>\n\tdouble-blind, placebo-controlled, eight-week Brintellix<sup style=\"line-height:0;\">®</sup> trials. All patients were switched to 10 mg/day Brintellix<sup style=\"line-height:0;\">®</sup> for <br>\n\tWeek 1, then adjusted between 15 mg and 20 mg for the remainder of the study, but not down-titrated below 15 mg. <br>\n\tOf the 1075 patients enrolled, 1073 received at least one dose of Brintellix<sup style=\"line-height:0;\">®</sup> and 538 (50.0%) completed the study. </span><br>\n\t<span style=\"display: inline-block;padding-top: 10px;\">FAS, full-analysis set; SDS, Sheehan disability scale.</span>\n</font>\n</p>",
	"Brintellix_31e0e23ee3": "<span style=\"font-family: &quot;3_CCMVBT+AvenirNextLTPro-Demi&quot;; color: rgb(84, 122, 129); \">\n<font style=\"font-size: 25px;\">References</font>\n</span>",
	"Brintellix_312d3b32d5": "<span style=\"font-family: &quot;2_PIDSIJ+AvenirNextLTPro-Regular&quot;; line-height: 1; color: rgb(100, 94, 94); display: block;\">\n<font style=\"font-size: 15px;\">\n\t<b>1.</b> Florea l et al. Brain Behav 2017;7:e00622.<br>&nbsp;<br>\n</font>\n</span>",
	"Brintellix_3140685874": "<span style=\"font-family: &quot;2_PIDSIJ+AvenirNextLTPro-Regular&quot;; line-height: 1; color: rgb(100, 94, 94); display: block;\">\n<font style=\"font-size: 15px;\">\n\t<b>2.</b> Jacobsen PL et al. Int Clin Psychopharmacol 2015;30:255–264.\n<br>\n</font>\n</span>",
	"Brintellix_313dcd6782": "Text",
	"Brintellix_3195881f6d": "Text",
	"Brintellix_31abfa2fba": "Text",
	"Brintellix_318af95e8f": "<span style=\"text-align: center; font-family: &quot;1_CWOXIJ+AvenirNextLTPro-Bold&quot;; line-height: 1; color: rgb(255, 255, 255); display: block;\"><font style=\"font-size: 14px;\">SDS\n</font>\n</span>",
	"kj8tvrnhText": "SDS<span class=\"_ _14\"> </span>UPSA<span class=\"_\"> </span>Summary<span class=\"_ _15\"></span><span class=\"ff1 fc3\">SDS</span>",
	"Brintellix_31abc6949b": "<span style=\"font-family: &quot;3_CCMVBT+AvenirNextLTPro-Demi&quot;; color: rgb(84, 122, 129); line-height: 1;\"><div style=\"text-align: center;\"><span style=\"font-size: 13px;\">UPSA&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Summary</span></div>\n</span>",
	"Brintellix_314868ed86": "Text",
	"Brintellix_31dc62c1de": "Text",
	"Brintellix_31ebc00e74": "Text",
	"Brintellix_31f6d81816": "Text",
	"Brintellix_31def3f0eb": "Text",
	"Brintellix_31791a1a38": "<span style=\"font-family: &quot;1_CWOXIJ+AvenirNextLTPro-Bold&quot;; color: rgb(84, 122, 129); \"><div style=\"text-align: center;\"><span style=\"font-size: 14.5px;\">Weeks in study</span></div>\n</span>",
	"Brintellix_31804250fb": "<span style=\"font-family: &quot;1_CWOXIJ+AvenirNextLTPro-Bold&quot;; color: rgb(84, 122, 129); \"><div style=\"text-align: center;\"><span style=\"font-size: 14.5px;\">Mean SDS total score</span></div>\n</span>",
	"Brintellix_3130fdebbd": "<div style=\"font-family: serif;font-family: '2_VDWFON+AvenirNextLTPro-Demi';font-size: 13px;color: #4d7f86;\">Cognitive Symptoms&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <span style=\"color: #fff;\">Functionality</span>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Motivation &amp; Energy&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Goal Attainment</div>"
}
